Immunic (IMUX) Other Working Capital Changes (2016 - 2026)
Immunic (IMUX) reported Other Working Capital Changes of -$149000.0 for Q1 2026, down 156.9% on a YoY basis from $261878.8 in Q1 2025, and up 55.92% sequentially from -$338000.0 in Q4 2025.
Immunic (IMUX) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Immunic (IMUX) has 6 years of Other Working Capital Changes data on file, last reported at -$149000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 156.9% year-over-year to -$149000.0; the trailing twelve-month figure through Mar 2026 stood at -$597000.0 (down 348.87% YoY), and the FY2025 full-year result was -$506000.0, down 96.89% from the prior year.
- Other Working Capital Changes advanced to -$149000.0 in Q1 2026, from -$338000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q4 2025 to a low of -$5.4 million in Q4 2022.
- A 5-year average of -$899411.8 and a median of -$389000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 68.13% in 2025, while the deepest fall reached 391.38% in 2025.
- Tracing IMUX's Other Working Capital Changes over 3 years: stood at $116000.0 in 2024, then plunged by 391.38% to -$338000.0 in 2025, then soared by 55.92% to -$149000.0 in 2026.
- Business Quant data shows IMUX's Other Working Capital Changes at -$149000.0 in Q1 2026, -$338000.0 in Q4 2025, and -$50000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149,000.00 |
| Mar 31, 2026 | -149,000.00 |
| Mar 31, 2026 | -149,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | -23,000.00 |
| Sep 30, 2024 | -23,000.00 |